Data / Form D filings / Pattern Bioscience, Inc.
Pattern Bioscience, Inc.: Form D filings
Pattern Bioscience, Inc., a biotechnology company in Austin, TX, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on August 18, 2025, reports $44.2 million sold of a $61.2 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9600 GREAT HILLS TR, SUITE 160E, Austin, TX, 78759
- Phone
- (512) 784-8706
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1735812
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | New notice | $61,221,338 | $44,221,343 | $16,999,995 | 6 | Jul 31, 2025 | sec.gov |
| Jan 12, 2023 | New notice | $31,999,992 | $23,499,993 | $8,499,999 | 4 | Dec 28, 2022 | sec.gov |
| Jul 10, 2020 | New notice | $9,000,007 | $6,000,001 | $3,000,006 | 1 | Jun 29, 2020 | sec.gov |
| Oct 23, 2019 | Amendment | $6,997,530 | $6,420,008 | $577,522 | 13 | Aug 30, 2019 | sec.gov |
| Sep 11, 2019 | New notice | $7,000,000 | $5,499,999 | $1,500,001 | 2 | Aug 30, 2019 | sec.gov |
| Apr 3, 2018 | New notice | $4,050,000 | $3,550,000 | $500,000 | 10 | Mar 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Junjun Gao | Director | |
| Scott Mendel | Director | |
| Greg Wood | Director | |
| Nicholas Naclerio | Director | |
| Patrick Balthrop | Director | |
| Nicolas Arab | Executive Officer, Director | |
| Carey-Ann Burnham | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pattern Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.